RA CAPITAL MANAGEMENT, L.P. bought $43.13 million of PepGen Inc. (NASDAQ: PEPG) stock on November 13th, 2026. The firm holds a director role at the company. The purchase covered 8,625,000 shares.

Every share in the transaction was acquired at $5.00. The price range on the filing runs from $5.00 to $5.00, which points to a single fixed-price block rather than a series of open-market fills at drifting prices. The buyer is an entity, not an individual officer, and the director seat is the basis for the reporting obligation.

PepGen Inc. operates in Pharmaceutical Preparations, a corner of the market where cash position and clinical timelines tend to drive the share price more than quarterly revenue does. The company carries a market capitalization of $365,733,792.

Size is the first thing worth weighing here. A $43.13 million purchase is a substantial sum set against a market capitalization of $365,733,792, and it arrived through one filing rather than being accumulated across many smaller reports.

The other side of the ledger is thin. Our tables show one filing for this buyer in the period covered, with no offsetting sales disclosed alongside it. A single transaction does not establish a pattern, and institutional buyers with board representation often transact in connection with financings rather than through routine open-market purchases. The filing itself does not state a motive, and readers should not assume one.

The price context cuts against the buyer so far. Shares were acquired at $5.00 and PepGen last traded at $3.88, which puts the position underwater relative to the transaction price. That gap is the plainest fact available to anyone reading this filing today. It also means the firm paid above the current market for the entire 8,625,000 share block.

Figures in this article come from the Form 4 filed with the Securities and Exchange Commission and from InsiderBuying.com's own reconciled transaction tables.

Track every Form 4 filed at PepGen Inc. (PEPG) → insiderbuying.com/companies/PEPG